AstraZeneca shares positive phase 3 results for Tagrisso in lung cancer

AstraZeneca shares positive phase 3 results for Tagrisso in lung cancer An estimated 2.2 million people worldwide are diagnosed with lung cancer each year. ... Lees verder

Bron:

Pharmamarketeer